Emmy Verschuren received her PhD in tumour biology from UCL in 2003, following graduate studies with Nic Jones at ICRF/CRUK in London, and Gerard Evan at UCSF in San Francisco. In 2003, she was awarded a Damon Runyon Fellowship for a postdoc with Peter Jackson at Stanford University to study cell cycle control by the ubiquitin ligase Emi1. In 2006, she moved with Peter to Genentech Inc. to continue her postdoc there. Emmy became a FIMM-EMBL Group Leader in 2009. From 2011-2016, she acted as the Academic Coordinator of the public-private IMI-PREDECT consortium. She serves on the Board of the European Association of Cancer Research (EACR). Since autumn 2018, she is appointed as FIMM’s strategic Research Coordinator.